Clinical Trials Browser

Phase 1/2 × Myeloproliferative Disorders × Captopril × Clear all

NCT04629651 2023-10-11

Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms

Phase 1/2 Withdrawn

Myeloproliferative Disorders, Primary Myelofibrosis